Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Dec 3, 2010


Aushon Biosystems has appointed Sven Beushausen to be its new chief scientific officer. He joins the Billerica, Mass.-based protein array technologies firm from Pfizer, where he was molecular medicine site leader.

Beushausen also has held other senior scientific positions within Pfizer, and previously worked as director of manufacturing technologies for Invitrogen (now Life Technologies).

Caris Life Sciences announced last week several recent additions and appointments to its senior scientific staff at its facilities in Lausanne, Switzerland, and Phoenix, Ariz.

Andy Tasinato was named director of research at the company's new R&D lab in Lausanne. Previously he was head of research at the University Hospital Lausanne and Bern. He will be overseeing Elodie Ristorcelli, who received her doctorate in biochemistry at the Faculty of Medicine in Marseille; and Gherici Hassaine, previously head of BioXtal's R&D laboratory.

Dan Holterman joined the company's Phoenix facility as a senior research scientist along with scientists Wang-Juh Chen, Jorge Schettini, and Tassilo Hornung.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.